Literature DB >> 6475456

Familial hypocalciuric hypercalcaemia: evidence for continued enhanced renal tubular reabsorption of calcium following total parathyroidectomy.

M Davies, P H Adams, G A Lumb, J L Berry, N Loveridge.   

Abstract

A patient with familial hypocalciuric hypercalcaemia (FHH) is reported. Seven years after total parathyroidectomy he remained hypocalcaemic, with biochemical evidence of hypoparathyroidism (enhanced renal tubular reabsorption of phosphate, low nephrogenic cyclic AMP excretion, and reduced serum concentration of 1,25-dihydroxycholecalciferol in the presence of normal renal function and normal serum 25-hydroxyvitamin D levels). Iv infusions of calcium were given before and 6 years after total parathyroidectomy. The renal tubular reabsorption of calcium was compared in these two situations. No difference was found. Before and after parathyroidectomy there was enhanced renal tubular reabsorption of calcium. It is concluded that the enhanced renal tubular reabsorption of calcium in FHH is independent of parathyroid hormone. Total parathyroidectomy corrects the hypercalcaemia in FHH by a reduction in the input of calcium into the extra-cellular fluid from gut and or bone perhaps as a result of reduced renal synthesis of 1,25-dihydroxycholecalciferol.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6475456     DOI: 10.1530/acta.0.1060499

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  3 in total

1.  In vivo and in vitro characterization of neonatal hyperparathyroidism resulting from a de novo, heterozygous mutation in the Ca2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia.

Authors:  M Bai; S H Pearce; O Kifor; S Trivedi; U G Stauffer; R V Thakker; E M Brown; B Steinmann
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

Review 2.  Familial hypocalciuric hypercalcaemia--familial benign hypercalcaemia: a review.

Authors:  J Auwerx; J Brunzell; R Bouillon; M Demedts
Journal:  Postgrad Med J       Date:  1987-10       Impact factor: 2.401

3.  The calcium-sensing receptor (CaSR) defends against hypercalcemia independently of its regulation of parathyroid hormone secretion.

Authors:  Lakshmi Kantham; Steven J Quinn; Ogo I Egbuna; Khanjan Baxi; Robert Butters; Jian L Pang; Martin R Pollak; David Goltzman; Edward M Brown
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-10       Impact factor: 4.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.